Smoking-related coronary heart disease in Denmark, Norway and Sweden and the impact of cessation with Zyban (bupropion HCl) compared with willpower

被引：0

作者：

Hogue, S

Orme, MO

Musin, AM

Olsen, NO

Istad, JA

Curry, AC

机构：

[1] GlaxoSmithKline, Global Hlth Outcomes, Res Triangle Pk, NC USA

[2] Lewin Grp, Bracknell, Berks, England

[3] Glaxo Smith Kline, Global Hlth Outcomes, Greenford, Middx, England

[4] Glaxo Smith Kline, Hlth Outcomes, Brondby, Denmark

[5] Glaxo Smith Kline, Hlth Outcomes, Oslo, Norway

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：722 / 722

页数：1